USA - NYSEARCA:PMI - US71953R1086 - Common Stock
The current stock price of PMI is 2.6 USD. In the past month the price decreased by -77.59%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 26.06 | 226.31B | ||
| ISRG | INTUITIVE SURGICAL INC | 63.5 | 195.98B | ||
| BSX | BOSTON SCIENTIFIC CORP | 34.49 | 150.78B | ||
| SYK | STRYKER CORP | 27.34 | 137.68B | ||
| BDX | BECTON DICKINSON AND CO | 13.24 | 54.74B | ||
| IDXX | IDEXX LABORATORIES INC | 53.05 | 53.52B | ||
| EW | EDWARDS LIFESCIENCES CORP | 32.97 | 49.75B | ||
| RMD | RESMED INC | 24.72 | 35.71B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 15.39 | 32.25B | ||
| PODD | INSULET CORP | 71.78 | 23.09B | ||
| DXCM | DEXCOM INC | 31.45 | 22.94B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 10.96 | 17.56B |
Picard Medical, Inc. is a medical technology company, which manufactures and sells the only U.S. FDA, and Health Canada approved implantable SynCardia TAH. The company is headquartered in Tucson, Arizona and currently employs 75 full-time employees. The company went IPO on 2025-08-29. SynCardia is a medical technology company that manufactures and sells the only United States Food and Drug Administration (FDA) and Health Canada-approved implantable total artificial heart (SynCardia TAH). The SynCardia TAH is a biventricular replacement device that consists of the SynCardia TAH implant, an external pneumatic driver that delivers precisely calibrated pulses of air to drive the implant, and drivelines that connect the driver to the implant. The SynCardia TAH implant is a system that consists of two independent artificial ventricles which are powered by an external pneumatic driver. Each artificial ventricle is made of a semi-rigid polyurethane housing and a rigid polyurethane base, with a four-layer flexible polyurethane diaphragm separating the blood chamber from the air chamber.
PICARD MEDICAL INC
1992 E. Silverlake Rd.
Tucson ARIZONA US
Employees: 75
Phone: 15203080796
Picard Medical, Inc. is a medical technology company, which manufactures and sells the only U.S. FDA, and Health Canada approved implantable SynCardia TAH. The company is headquartered in Tucson, Arizona and currently employs 75 full-time employees. The company went IPO on 2025-08-29. SynCardia is a medical technology company that manufactures and sells the only United States Food and Drug Administration (FDA) and Health Canada-approved implantable total artificial heart (SynCardia TAH). The SynCardia TAH is a biventricular replacement device that consists of the SynCardia TAH implant, an external pneumatic driver that delivers precisely calibrated pulses of air to drive the implant, and drivelines that connect the driver to the implant. The SynCardia TAH implant is a system that consists of two independent artificial ventricles which are powered by an external pneumatic driver. Each artificial ventricle is made of a semi-rigid polyurethane housing and a rigid polyurethane base, with a four-layer flexible polyurethane diaphragm separating the blood chamber from the air chamber.
The current stock price of PMI is 2.6 USD. The price decreased by -3.7% in the last trading session.
PMI does not pay a dividend.
PMI has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 0 out of 10.
PMI stock is listed on the NYSE Arca exchange.
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on PMI.
PICARD MEDICAL INC (PMI) has a market capitalization of 191.62M USD. This makes PMI a Micro Cap stock.
Over the last trailing twelve months PMI reported a non-GAAP Earnings per Share(EPS) of -0.33. The EPS decreased by -31.86% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -202.83% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |